MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia

References

• Ma X, Does M, Raza A, et al. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109:1536–1542.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues , vol. 2, 4th ed. Lyon, France: IARC Press; 2008.
   Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088.
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–2465.
   PubMed Web of Science ®Google Scholar
• Greenberg PL. The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features. J Natl Compr Cancer Netw. 2013;11:877–885.
   PubMed Web of Science ®Google Scholar
• Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28:241–247.
   PubMed Web of Science ®Google Scholar
• Kuendgen A, Seidler J, Lauseker M, et al. Prognostic impact of molecular mutations in 182 patients with myelodysplastic syndromes. Blood. 2013;122:2758.
   Web of Science ®Google Scholar
• Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125:1367–1376.
   PubMed Web of Science ®Google Scholar
• Bejar R, Stevenson KE, Caughey BA, et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012;30:3376–3382.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med. 2010;16:49–58.
   PubMed Web of Science ®Google Scholar
• Dostalova Merkerova M, Krejcik Z, Votavova H, et al. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Eur J Hum Genet. 2011;19:313–319.
   PubMed Web of Science ®Google Scholar
• Erdogan B, Facey C, Qualtieri J, et al. Diagnostic microRNAs in myelodysplastic syndrome. Exp Hematol. 2011;39:915–926. e2.
   PubMed Web of Science ®Google Scholar
• Hussein K, Theophile K, Busche G, et al. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. Leuk Res. 2010;34:1169–1174.
   PubMed Web of Science ®Google Scholar
• Pons A, Nomdedeu B, Navarro A, et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma. 2009;50:1854–1859.
   PubMed Web of Science ®Google Scholar
• Sokol L, Caceres G, Volinia S, et al. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011;153:24–32.
   PubMed Web of Science ®Google Scholar
• Xu F, Zhu Y, He Q, et al. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes. Sci Rep. 2016;6:32232.
   PubMed Web of Science ®Google Scholar
• Cammarata G, Augugliaro L, Salemi D, et al. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am J Hematol. 2010;85:331–339.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Pelosi E, Castelli G, et al. A miRNA signature in human cord blood stem and progenitor cells as potential biomarker of specific acute myeloid leukemia subtypes. J Cell Physiol. 2015;230:1770–1780.
   PubMed Web of Science ®Google Scholar
• Eyholzer M, Schmid S, Schardt JA, et al. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res. 2010;34:672–676.
   PubMed Web of Science ®Google Scholar
• Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111:3183–3189.
   PubMed Web of Science ®Google Scholar
• Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA. 2008;105:3945–3950.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Mrozek K, Radmacher MD, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117:1121–1129.
   PubMed Web of Science ®Google Scholar
• Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003;5:R1.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell. 2003;115:787–798.
   PubMed Web of Science ®Google Scholar
• Stark A, Brennecke J, Russell RB, et al. Identification of Drosophila MicroRNA targets. PLoS Biol. 2003;1:E60.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68–D73.
   PubMed Web of Science ®Google Scholar
• Fu Y, Lee I, Lee YS, et al. Small non-coding transfer RNA-derived RNA fragments (tRFs): their biogenesis, function and implication in human diseases. Genomics Inform. 2015;13:94.
   PubMedGoogle Scholar
• Fu H, Feng J, Liu Q, et al. Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett. 2009;583:437–442.
   PubMed Web of Science ®Google Scholar
• Diebel KW, Zhou K, Clarke AB, et al. Beyond the ribosome: extra-translational functions of tRNA fragments. Biomarker Insights. 2016;11:1–8.
   Google Scholar
• Goodarzi H, Liu X, Nguyen HCB, et al. Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement. Cell. 2015;161:790–802.
   PubMed Web of Science ®Google Scholar
• Kumar P, Anaya J, Mudunuri SB, et al. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol. 2014;12:78.
   PubMed Web of Science ®Google Scholar
• Olvedy M, Scaravilli M, Hoogstrate Y, et al. A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget. 2016;7:24766–24777.
   Google Scholar
• Venkatesh T, Suresh PS, Tsutsumi R. TRFs: MiRNAs in disguise. Gene. 2016;579:133–138.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
   PubMed Web of Science ®Google Scholar
• Guo Y, Bosompem A, Mohan S, et al. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics. 2015;16:727–737.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Roteta LA, Hucheson-Dilks H, et al. Mining diverse small RNA species in the deep transcriptome. Trends Biochem Sci. 2015;40:4–7.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10–12.
   Google Scholar
• Guo Y, Zhao S, Sheng Q, et al. Multi-perspective quality control of Illumina exome sequencing data using QC3. Genomics. 2014;103:323–328.
   PubMed Web of Science ®Google Scholar
• Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
   PubMed Web of Science ®Google Scholar
• Berezikov E, Robine N, Samsonova A, et al. Deep annotation of Drosophila melanogaster microRNAs yields insights into their processing, modification, and emergence. Genome Res. 2011;21:203–215.
   PubMed Web of Science ®Google Scholar
• Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol. 2008;23:1635–1648.
   PubMed Web of Science ®Google Scholar
• Rajagopalan R, Vaucheret H, Trejo J, et al. A diverse and evolutionarily fluid set of microRNAs in Arabidopsis thaliana. Genes Dev. 2006;20:3407–3425.
   PubMed Web of Science ®Google Scholar
• Westholm JO, Ladewig E, Okamura K, et al. Common and distinct patterns of terminal modifications to mirtrons and canonical microRNAs. RNA. 2012;18:177–192.
   PubMed Web of Science ®Google Scholar
• Chan PP, Lowe TM. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res. 2009;37:D93–D97.
   PubMed Web of Science ®Google Scholar
• Flicek P, Amode MR, Barrell D, et al. Ensembl 2014. Nucleic Acids Res. 2014;42:D749–D755.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhao S, Ye F, et al. MultiRankSeq: multiperspective approach for RNAseq differential expression analysis and quality control. Biomed Res Int. 2014;2014:8.
   Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodological. 1995;57:289–300.
   Web of Science ®Google Scholar
• Su R, Lin HS, Zhang XH, et al. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene. 2015;34:3226–3239.
   PubMed Web of Science ®Google Scholar
• Xiong Q, Yang Y, Wang H, et al. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines. Genomics Proteomics Bioinformatics. 2014;12:79–91.
   PubMedGoogle Scholar
• Yoshizawa S, Ohyashiki JH, Ohyashiki M, et al. Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J. 2012;2:e53. doi: 10.1038/bcj.2011.51.
   PubMed Web of Science ®Google Scholar
• Ovcharenko D, Stolzel F, Poitz D, et al. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Exp Hematol. 2011;39:1030–1042.
   PubMed Web of Science ®Google Scholar
• Qian J, Lin J, Qian W, et al. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia. Leuk Res. 2013;37:765–768.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Maharry K, Wu YZ, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol. 2010;28:2348–2355.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Metzeler KH, Schwind S, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol. 2012;30:742–750.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen J. In vitro functional study of miR-126 in leukemia. Methods Mol Biol. 2011;676:185–195.
   PubMedGoogle Scholar
• Wang XS, Gong JN, Yu J, et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood. 2012;119:4992–5004.
   PubMed Web of Science ®Google Scholar
• Whitman SP, Maharry K, Radmacher MD, et al. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. 2010;116:3622–3626.
   PubMed Web of Science ®Google Scholar
• Vlachos IS, Kostoulas N, Vergoulis T, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012;40:W498–504.
   PubMed Web of Science ®Google Scholar
• Weng H, Lal K, Yang FF, et al. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia. Cancer Genet. 2015;208:225–229.
   PubMed Web of Science ®Google Scholar
• Favreau AJ, Duarte CW, Sathyanarayana P. Mir-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications in FAB-M5 subtype. Blood. 2013;122.
   Google Scholar
• Favreau AJ, McGlauflin RE, Duarte CW, Sathyanarayana P. miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications. Exp Hematol Oncol. 2013;38:984–997.
   Google Scholar
• Williams A, Henao-Mejia J, Harman CCD, et al. miR-181 and metabolic regulation in the immune system. Cold Spring Harb Symp Quant Biol. 2013;78:223–230.
   PubMedGoogle Scholar
• Martelli AM, Nyåkern M, Tabellini G, et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK. 2006;20:911–928.
   PubMed Web of Science ®Google Scholar
• Ivanov P, O’Day E, Emara MM, et al. G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments. Proc Natl Acad Sci USA. 2014;111:18201–18206.
   PubMed Web of Science ®Google Scholar
• Newman MA, Mani V, Hammond SM. Deep sequencing of microRNA precursors reveals extensive 3' end modification. RNA. 2011;17:1795–1803.
   PubMed Web of Science ®Google Scholar
• Wyman SK, Knouf EC, Parkin RK, et al. Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res. 2011;21:1450–1461.
   PubMed Web of Science ®Google Scholar
• Xu L, Xu Y, Jing Z, et al. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Exp Hematol Oncol. 2014;3:17.
   PubMedGoogle Scholar
• Seyyedi SS, Soleimani M, Yaghmaie M, et al. Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics. Tumor Biol. 2016;37:4841–4847.
   PubMed Web of Science ®Google Scholar
• Zhi YJ, Xie XB, Wang R, et al. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. Int J Hematol. 2015;102:296–303.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Z, He C, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis. 2010;44:191–197.
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong KY, Leung CY, et al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J Cell Mol Med. 2011;15:2760–2767.
   PubMed Web of Science ®Google Scholar
• De Leeuw DC, Van Den Ancker W, Denkers F, et al. MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia. Clin Cancer Res. 2013;19:2187–2196.
   PubMed Web of Science ®Google Scholar